GAP Supply Act

HR 7528, the GAP Supply Act, extends a compliance deadline for pharmaceutical outsourcing facilities. It amends Section 503B of the Federal Food, Drug, and Cosmetic Act to require these facilities to compound and distribute drugs during shortages within 180 calendar days, instead of immediately. This change directly affects facilities that handle compounded drugs, providing them additional time to meet requirements during supply shortages. The bill focuses on improving drug supply chain stability by adjusting the timeline for facility compliance, without altering the core regulatory standards.